Avadel Pharmaceuticals Reports First Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Avadel Pharma (AVDL) Reports Q1 EPS of $0.26, Offers Guidance
May 9, 2017 7:39 AM EDTAvadel Pharma (NASDAQ: AVDL) reported Q1 EPS of $0.26, versus $0.04 reported last year. Revenue for the quarter came in at $52.5 million, versus $36.2 million reported last year.
2017 Guidance
The Company is increasing its full year adjusted EPS guidance to a range of $0.30 to $0.45 per... More
